LIXACOL Trademark

Trademark Overview

On Wednesday, January 27, 2016, a trademark application was filed for LIXACOL with the United States Patent and Trademark Office. The USPTO has given the LIXACOL trademark a serial number of 79183814. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 29, 2023. This trademark is owned by Tillotts Pharma AG. The LIXACOL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, in particular for the diagnosis, prevention and treatment of gastrointestinal disorders and conditions; pharmaceutical preparation for the treatment of inflammation; pharmaceutical preparations containing glucocorticoid steroids; dietetic substances in the nature of oral diagnostic preparations and oral pharmaceutical preparations adapted for medical use, in particular for the diagnosis, prevention and treatment of gastrointestinal disorders and conditions
lixacol

General Information

Serial Number79183814
Word MarkLIXACOL
Filing DateWednesday, January 27, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 29, 2023
Registration Number5220227
Registration DateTuesday, June 13, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, in particular for the diagnosis, prevention and treatment of gastrointestinal disorders and conditions; pharmaceutical preparation for the treatment of inflammation; pharmaceutical preparations containing glucocorticoid steroids; dietetic substances in the nature of oral diagnostic preparations and oral pharmaceutical preparations adapted for medical use, in particular for the diagnosis, prevention and treatment of gastrointestinal disorders and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTillotts Pharma AG
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressCH-4310 Rheinfelden
CH
Party NameTillotts Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressCH-4310 Rheinfelden
CH
Party NameTillotts Pharma AG
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressCH-4310 Rheinfelden
CH

Trademark Events

Event DateEvent Description
Tuesday, November 8, 2016FAX RECEIVED
Thursday, March 3, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 8, 2016APPLICATION FILING RECEIPT MAILED
Thursday, May 12, 2016ASSIGNED TO EXAMINER
Thursday, May 12, 2016NON-FINAL ACTION WRITTEN
Friday, May 13, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 13, 2016REFUSAL PROCESSED BY MPU
Friday, May 13, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, July 16, 2016REFUSAL PROCESSED BY IB
Monday, February 6, 2017AMENDMENT FROM APPLICANT ENTERED
Tuesday, November 8, 2016FAX RECEIVED
Wednesday, November 16, 2016PAPER RECEIVED
Wednesday, December 7, 2016ASSIGNED TO LIE
Thursday, December 22, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 22, 2016AMENDMENT FROM APPLICANT ENTERED
Thursday, December 22, 2016REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Thursday, December 22, 2016NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
Monday, January 30, 2017FAX RECEIVED
Monday, February 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 8, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 8, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, September 18, 2017FINAL DISPOSITION PROCESSED
Monday, February 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 8, 2017NOTICE OF PUBLICATION
Tuesday, June 13, 2017REGISTERED-PRINCIPAL REGISTER
Saturday, July 8, 2017NOTIFICATION PROCESSED BY IB
Friday, August 30, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 6, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, September 6, 2024INVALIDATION PROCESSED
Monday, September 18, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 29, 2023CANCELLED SECTION 71

Related Keywords

lixacol pharmaceutical preparations treatment conditions oral gastrointestinal disorders particular diagnosis prevention